3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
35
Phase NA
11
Phase 2
8
Phase 1/2
8
Phase 3
2
Phase EARLY_PHASE1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
22
Breast
5
Thoracic
4
Head & Neck
3
Gynecologic
2
Sarcoma
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Conditions
Sarcoma
35
Glioblastoma
10
Breast Neoplasms
9
Gliosarcoma
8
Osteosarcoma
7
Melanoma
7
Bone Neoplasms
7
Stomach Neoplasms
6
Pancreatic Neoplasms
6
Ovarian Neoplasms
6
Lung Neoplasms
6
Head and Neck Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Sarcoma, Alveolar Soft Part
4
Colorectal Neoplasms
4
Colonic Neoplasms
4
Brain Neoplasms
4
Rectal Neoplasms
3
Oligodendroglioma
3
Neoplasms
3
Lymphoma
3
Liver Neoplasms
3
Gastrointestinal Neoplasms
3
Desmoplastic Small Round Cell Tumor
3
Dendritic Cell Sarcoma, Interdigitating
3
Astrocytoma
3
Small Cell Lung Carcinoma
2
Sarcoma, Synovial
2
Sarcoma, Kaposi
2
Rhabdomyosarcoma
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Urinary Bladder Neoplasms
×
Sarcoma
×
Clear all
NCT06645808
2025-12-29
VARTUTRACE
Var2 Pharmaceuticals
Phase EARLY_PHASE1
Recruiting
32 enrolled